Suchergebnisse - "Kowdley, Kris V"

PubPharm (646)

1

PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic-associated steatotic liver disease

enthalten in: Hepatology (Baltimore, Md.) | 2024

von Chalasani, N. | Vilar-Gomez, E. | Loomba, R. | +9

2

Novel preclinical developments of the primary sclerosing cholangitis treatment landscape

enthalten in: Expert opinion on investigational drugs | 2024

von Sohal, A. | Kowdley, K.

3

Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting

enthalten in: Postgraduate medicine | 2024

von Allen, A. | Charlton, M. | Cusi, K. | +4

4

A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis

enthalten in: Hepatology (Baltimore, Md.) | 2024

von Rinella, M. | Lieu, H. | Kowdley, K. | +16

5

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

enthalten in: The New England journal of medicine | 2024

von Kowdley, K. | Bowlus, C. | Levy, C. | +102

6

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis

enthalten in: The New England journal of medicine | 2024

von Hirschfield, G. | Bowlus, C. | Mayo, M. | +94

7

A Review of New Concepts in Iron Overload

enthalten in: Gastroenterology & hepatology | 2024

von Sohal, A. | Kowdley, K.

8

Rusfertide for iron overload in haemochromatosis - Authors' reply

enthalten in: The lancet. Gastroenterology & hepatology | 2024

von Kowdley, K. | Modi, N. | Valone, F.

9

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

enthalten in: Annals of hepatology | 2024

von Rinella, M. | Lazarus, J. | Ratziu, V. | +51

10

Complete Biochemical Remission With Oral Vancomycin in a Patient With Primary Sclerosing Cholangitis and High Serum Immunoglobulin G4 Levels

enthalten in: ACG case reports journal | 2024

von Sohal, A. | Kowdley, K.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[65]